HCA Healthcare, Inc. $HCA is Darsana Capital Partners LP's 6th Largest Position

Key Points

• Darsana Capital Partners increased its HCA Healthcare stake by 46.7% in the second quarter to 1.1 million shares valued at approximately $428.9 million, making HCA its sixth-largest holding. Institutional investors collectively own 62.73% of the company.
• Analysts maintain a generally positive outlook, with 14 Buy, eight Hold, and one Sell rating. HCA has a consensus rating of “Moderate Buy” and an average price target of $462.64.
• HCA exceeded quarterly expectations with $7.59 in earnings per share and $20.23 billion in revenue, up 8.7% year over year. The company also declared a quarterly dividend of $0.78 per share, representing a 0.7% annualized yield.

Darsana Capital Partners LP raised its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 46.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,100,000 shares of the company's stock after purchasing an additional 350,000 shares during the quarter. HCA Healthcare accounts for approximately 1.9% of Darsana Capital Partners LP's holdings, making the stock its 6th biggest holding. Darsana Capital Partners LP owned approximately 0.51% of HCA Healthcare worth $428,879,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of HCA. Cidel Asset Management Inc. grew its position in HCA Healthcare by 8.0% in the 2nd quarter. Cidel Asset Management Inc. now owns 1,585 shares of the company's stock valued at $618,000 after acquiring an additional 118 shares during the last quarter. Capital Analysts LLC increased its stake in HCA Healthcare by 10.3% in the 2nd quarter. Capital Analysts LLC now owns 642 shares of the company's stock worth $250,000 after buying an additional 60 shares during the period. NewEdge Advisors LLC boosted its position in HCA Healthcare by 6.5% in the 2nd quarter. NewEdge Advisors LLC now owns 9,918 shares of the company's stock valued at $3,867,000 after buying an additional 609 shares during the period. IFP Advisors Inc boosted its holdings in shares of HCA Healthcare by 4.1% in the second quarter. IFP Advisors Inc now owns 9,563 shares of the company's stock valued at $3,729,000 after purchasing an additional 377 shares during the period. Finally, Empirical Finance LLC increased its holdings in HCA Healthcare by 2.3% during the 2nd quarter. Empirical Finance LLC now owns 7,140 shares of the company's stock worth $2,784,000 after purchasing an additional 161 shares during the period. Hedge funds and other institutional investors own 62.73% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. Royal Bank Of Canada restated an "outperform" rating and set a $435.00 price target on shares of HCA Healthcare in a research note on Tuesday. JPMorgan Chase & Co. reduced their price target on shares of HCA Healthcare from $490.00 to $425.00 and set a "neutral" rating for the company in a report on Thursday, August 20th. Cantor Fitzgerald reduced their price objective on shares of HCA Healthcare from $588.00 to $525.00 and set an "overweight" rating for the company in a research note on Tuesday, July 7th. Raymond James Financial set a $528.00 price target on HCA Healthcare in a report on Tuesday, July 7th. Finally, Wells Fargo & Company raised their price objective on HCA Healthcare from $369.00 to $381.00 and gave the company an "equal weight" rating in a research report on Monday, August 3rd. Fourteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of "Moderate Buy" and a consensus target price of $462.64.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $422.47 on Thursday. The firm has a fifty day moving average price of $404.41 and a 200 day moving average price of $434.23. The stock has a market cap of $91.47 billion, a PE ratio of 14.14, a price-to-earnings-growth ratio of 1.32 and a beta of 1.10. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating analysts' consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company's revenue was up 8.7% on a year-over-year basis. During the same quarter last year, the business posted $6.84 EPS. As a group, equities analysts expect that HCA Healthcare, Inc. will post 29.42 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is presently 10.45%.

HCA Healthcare Profile

HCA Healthcare, Inc NYSE: HCA is a healthcare services company that operates hospitals and other healthcare facilities. Its network provides a broad range of medical services, including emergency care, inpatient and outpatient treatment, surgery, diagnostic services, and maternity care.

The company also operates ambulatory surgery centers, urgent care facilities, physician practices, and other outpatient locations. HCA Healthcare serves patients through facilities located across the United States, as well as through HCA Healthcare UK, its healthcare operations in the United Kingdom.

HCA Healthcare was founded in 1968 by Dr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.